MedTrace Logo

Explorative Proteomics in Pediatric Neuroborreliosis

NCT06579235 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2024-09-03

No results posted yet for this study

Summary

This study aims to use proteomic analysis to diagnose Lyme Neuroborreliosis (LNB) in children. Pediatric patients with suspected LNB will be enrolled, and their blood samples will be collected for proteomic analyses. Mass spectrometry will be used to compare protein profiles of LNB-positive and LNB-negative patients. The data will be analyzed by bioinformaticians. The expected impact is to establish a non-invasive, reliable method for early LNB diagnosis to improve patient outcomes.

Conditions

  • Neuroborreliosis
  • Facial Palsy
  • Pediatric Infectious Disease

Interventions

DIAGNOSTIC_TEST

Proteomics

All samples of cases (with LNB) and controls (without LNB) will undergo proteomic analyses.

Sponsors & Collaborators

  • Clinical Proteomics, Department of Clinical Biochemistry, Bispebjerg Hospital

    collaborator UNKNOWN

  • NNF Center for Protein Research, University of Copenhagen

    collaborator UNKNOWN

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-17
Primary Completion
2023-10-10
Completion
2024-12-10

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06579235 on ClinicalTrials.gov